• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PPIs and anti-TNF in patients with IBD: a forbidden combination?

作者信息

Wellens Judith, Sabino João, Vermeire Séverine

机构信息

Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium

Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.

出版信息

Gut. 2021 Dec;70(12):2397-2398. doi: 10.1136/gutjnl-2021-324040. Epub 2021 Jan 29.

DOI:10.1136/gutjnl-2021-324040
PMID:33514599
Abstract
摘要

相似文献

1
PPIs and anti-TNF in patients with IBD: a forbidden combination?炎症性肠病患者使用质子泵抑制剂和抗肿瘤坏死因子药物：禁忌组合？
Gut. 2021 Dec;70(12):2397-2398. doi: 10.1136/gutjnl-2021-324040. Epub 2021 Jan 29.
2
Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis.比较英夫利昔单抗和阿达木单抗对炎症性肠病女性妊娠结局的安全性：系统评价与荟萃分析。
BMC Pregnancy Childbirth. 2022 Nov 19;22(1):854. doi: 10.1186/s12884-022-05191-z.
3
Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy.抗 TNF 治疗炎症性肠病患者皮肤反应的系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):346-357. doi: 10.1097/MEG.0000000000001917.
4
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.肿瘤坏死因子拮抗剂对原发性硬化性胆管炎患者的影响。
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2295-2304.e2. doi: 10.1016/j.cgh.2020.02.014. Epub 2020 Feb 15.
5
Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients.老年炎症性肠病患者抗 TNF 治疗的停药率增加。
J Crohns Colitis. 2020 Jul 30;14(7):888-895. doi: 10.1093/ecco-jcc/jjaa012.
6
Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?抗 TNF 药物给药间隔延长：炎症性肠病患者的有效策略？
Dig Dis Sci. 2020 Jul;65(7):2036-2043. doi: 10.1007/s10620-019-06010-w. Epub 2019 Dec 19.
7
Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease.焦虑和抑郁导致炎症性肠病中抗肿瘤坏死因子的停药。
Clin Gastroenterol Hepatol. 2021 Jun;19(6):1200-1208.e1. doi: 10.1016/j.cgh.2020.07.013. Epub 2020 Jul 12.
8
Letter: predictive factors for treatment discontinuation in IBD-anti-TNF trough levels and anti-drug antibodies.
Aliment Pharmacol Ther. 2021 Aug;54(4):536-537. doi: 10.1111/apt.16494.
9
Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease.比较肿瘤坏死因子拮抗剂单独使用与联合免疫调节剂治疗炎症性肠病患者的应答丢失情况。
Korean J Intern Med. 2021 Mar;36(Suppl 1):S9-S17. doi: 10.3904/kjim.2019.279. Epub 2020 Jun 25.
10
Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy.抗 TNF 治疗的炎症性肠病儿科患者的皮肤表现。
Inflamm Bowel Dis. 2018 Aug 16;24(9):2086-2092. doi: 10.1093/ibd/izy112.